» Articles » PMID: 33128353

A Research of STEAP1 Regulated Gastric Cancer Cell Proliferation, Migration and Invasion in Vitro and in Vivos

Overview
Journal J Cell Mol Med
Date 2020 Oct 31
PMID 33128353
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Six-Transmembrane Epithelial Antigene of the Prostate 1 (STEAP1) is associated with the occurrence and development of cancer. This study aimed to clarify the role of STEAP1 in gastric cancer tumour growth and metastasis, as well as its molecular mechanism of action.Statistical methods were used for clinical data analysis. Protein expression was detected using immunohistochemistry(IHC). The mRNA and protein expression in the cell cultures were detected using reverse transcription-polymerase chain reaction(RT-PCR) and western blot analysis. Overexpression and silencing models were constructed using plasmid and lentivirus transfection. To detect cell proliferation in vitro, Cell Counting Kit-8(CCK-8), flow cytometry and colony formation assays were used; transwell and wound healing assays were used to detect cell migration and invasion;For in vivo experiments, nude BALB/c mice were used for detecting subcutaneous tumorigenesis and intraperitoneal implantation. In the results,we found STEAP1 was overexpressed in gastric cancer tissues and cell lines. Single-factor and Cox analyses showed that STEAP1 gene expression level correlated with poor prognosis. Up-regulation of STEAP1 increased cell proliferation, migration and invasion, which decreased after STEAP1 was knocked down. These changes were achieved via the activation of the AKT/FoxO1 pathway and epithelial-mesenchymal transformation (EMT). The in vivo animal experiments showed that STEAP1 knock down, resulted in a decrease in the subcutaneous tumour and peritoneal tumour formation.

Citing Articles

Inflammatory response in gastrointestinal cancers: Overview of six transmembrane epithelial antigens of the prostate in pathophysiology and clinical implications.

Fang Z, Chen W, Wu Z, Hou Y, Lan Y, Wu H World J Clin Oncol. 2024; 15(1):9-22.

PMID: 38292664 PMC: 10823946. DOI: 10.5306/wjco.v15.i1.9.


A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family.

Fu D, Zhang X, Zhou Y, Hu S BMC Med Genomics. 2024; 17(1):16.

PMID: 38191397 PMC: 10775544. DOI: 10.1186/s12920-023-01789-0.


Targeting STEAP1 as an anticancer strategy.

Nakamura H, Arihara Y, Takada K Front Oncol. 2023; 13:1285661.

PMID: 37909017 PMC: 10613890. DOI: 10.3389/fonc.2023.1285661.


STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel.

Rocha S, Nascimento D, Coelho R, Cardoso A, Passarinha L, Socorro S Int J Mol Sci. 2023; 24(7).

PMID: 37047621 PMC: 10095014. DOI: 10.3390/ijms24076643.


Specific Six-Transmembrane Epithelial Antigen of the Prostate 1 Capture with Gellan Gum Microspheres: Design, Optimization and Integration.

Batista-Silva J, Gomes D, Barroca-Ferreira J, Gallardo E, Sousa A, Passarinha L Int J Mol Sci. 2023; 24(3).

PMID: 36768273 PMC: 9916199. DOI: 10.3390/ijms24031949.


References
1.
Buccione R, Caldieri G, Ayala I . Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 2009; 28(1-2):137-49. DOI: 10.1007/s10555-008-9176-1. View

2.
Deep G, Singh R, Agarwal C, Kroll D, Agarwal R . Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene. 2005; 25(7):1053-69. DOI: 10.1038/sj.onc.1209146. View

3.
Hou B, Li W, Li J, Ma J, Xia P, Liu Z . Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway. Oncol Rep. 2020; 43(2):536-548. PMC: 6967159. DOI: 10.3892/or.2019.7442. View

4.
Jia Y, Dong B, Tang L, Liu Y, Du H, Yuan P . Apoptosis index correlates with chemotherapy efficacy and predicts the survival of patients with gastric cancer. Tumour Biol. 2012; 33(4):1151-8. DOI: 10.1007/s13277-012-0357-8. View

5.
Cheung I, Feng Y, Danis K, Shukla N, Meyers P, Ladanyi M . Novel markers of subclinical disease for Ewing family tumors from gene expression profiling. Clin Cancer Res. 2007; 13(23):6978-83. DOI: 10.1158/1078-0432.CCR-07-1417. View